UNC researchers find clue to stopping breast-cancer metastasis

November 18, 2008

CHAPEL HILL - If scientists knew exactly what a breast cancer cell needs to spread, then they could stop the most deadly part of the disease: metastasis. New research from the University of North Carolina at Chapel Hill School of Medicine takes a step in that direction.

Carol Otey, Ph.D. and UNC colleagues reduced the ability of breast cancer cells to migrate by knocking down the expression of a protein called palladin.

They also found higher levels of palladin in four invasive breast cancer cell lines compared to four non-invasive cell lines.

"This study shows that palladin may play an important role in the metastasis of breast cancer cells as they move out of the tumor and into the blood vessels and lymphatics to spread throughout the body," said Otey, associate professor of cell and molecular physiology.

To conduct the study, the researchers grew breast cancer cells in an "invasion chamber," in which human tumor cells are placed in a plastic well that is inserted into a larger well. Cells will attempt to move to the bottom of the chamber because it's baited with growth factors that cells find attractive. But first the cells have to migrate through a filter coated with a layer of artificial connective tissue. "The cells have to migrate through that and have to degrade it," Otey said. "It's a useful model system that mimics what happens in the body."

The study results appeared in the Nov. 3, 2008, online edition of the journal Oncogene.

Most women would never die from breast cancer if the cancer cells couldn't metastasize to the brain and bone marrow, Otey said. "To really make breast cancer a treatable disease, we have to be able to find a way to prevent or reduce the amount of metastasis."

"Now that we see palladin is expressed mostly in invasive cells, it raises the question as to whether it might be useful as a prognostic marker," Otey said. "Maybe someday doctors could test for the presence of palladin to identify patients who have the most aggressive tumors, then give those patients personalized, more aggressive treatment."

The study benefited from the collaboration between Otey's cell and molecular physiology lab and Dr. Hong Jin ("H.J.") Kim's surgical oncology lab. "I learned a lot from H.J. about the challenges that clinicians face as they try to optimize the treatment of each breast cancer patient," Otey said.

Otey has been investigating palladin's role in cell movement since she discovered and named it in 2000.

Next she will examine a variety of samples of human tumors from a UNC tumor bank, to find out if the tumors from patients who had worse outcomes and more aggressive cancers contain higher levels of palladin.

University of North Carolina School of Medicine

---

---

	100 Questions & Answers About Advanced & Metastatic Breast Cancer by Lillie D. Shockney (Author), Gary R. Shapiro (Author) EMPOWER YOURSELF! Whether You're A Newly Diagnosed Patient, Survivor, Or Loved One Of Someone Suffering From Advanced Breast Cancer, 100 Questions & Answers About Advanced And Metastatic Breast Cancer, Second Edition Offers Essential And Practical Guidance. Providing Both Doctor And Patient Perspectives, This Updated And Revised Edition Offers Authoritative Answers To The Most Commonly Asked Questions About Advanced And Metastatic Breast Cancer Including Diagnosis, Treatment, Post-Treatment Quality Of Life, Alternative Medicine, Targeted Therapy, And Coping Strategies. Written By Experts From Johns Hopkins University And Medical Center, This New Edition Is An Invaluable Resource For Anyone Coping With The Physical And Emotional Turmoil Of This Disease.
	Handbook of Metastatic Breast Cancer, Second Edition by Charles Swanton (Editor), Stephen R. D. Johnston (Editor) About one third of women diagnosed with breast cancer will develop metastatic disease and subsequently die from their advanced breast cancer. Recent developments with novel systemic drugs, palliative surgical techniques and diagnostic imaging have given hope for the treatment of patients whose breast cancer has spread beyond its primary tumour. Written by a team from leading cancer centres in Europe, including the UK's Royal Marsden Hospital, the Handbook of Metastatic Breast Cancer, Second Edition provides advanced scientific information and guidance on clinical problems associated with metastatic breast cancer. Highlights of the Second Edition include: New chapters on specialist treatment options, gene expression signatures, biomarkers, and specialist support services for patients and...
	Advanced Breast Cancer: A Guide to Living with Metastatic Disease, 2nd Edition (Patient-Centered Guides) by Musa Mayer (Author) An estimated two million Americans alive today have been diagnosed with breast cancer. Each one of them lives with the fear of recurrence, and for good reason: for at least a third of women diagnosed with breast cancer, the disease will eventually spread. When this happens most people assume it means an immediate death sentence. The reality is often different, as explained in Advanced Breast Cancer: A Guide to Living with Metastatic Disease. Newly updated and revised, this is the only book on breast cancer that deals honestly with the realities of metastatic disease, yet offers hope and comfort.All aspects of dealing with the disease are covered, including:Coping with the shock of recurrence Seeking information and making treatment decisions Communicating effectively with medical...
	Inflammatory Breast Cancer: An Update by Naoto T. Ueno (Editor), Massimo Cristofanilli (Editor) Inflammatory breast cancer is the most deadly subtype of breast cancer because it can spread to other organs despite of multidisciplinary approach. However, the molecular characteristic of this aggressive disease is yet to be established. This book is the one of the few textbooks that summarizes the latest information dated to inflammatory breast cancer. The uniqueness of this book is that it has summarized the latest molecular and mechanistic findings, which may lead to novel diagnostic tool or therapeutic approach to fight this deadly disease.
	After Breast Cancer: A Common-Sense Guide to Life After Treatment by Hester Hill Schnipper LICSW (Author) As women quickly discover, their life when treatment ends is very different from what it was before their diagnosis. Often exhausted, anxious, and emotionally volatile, they are beset by physical discomforts, fearful of intimacy, afraid for their children, worried about recurrence. Anticipating a return to “normalcy,” they discover that the old version of normal no longer applies. There could be no more knowledgeable guide for women embarking on this complicated journey than Hester Hill Schnipper, who is herself both an experienced oncology social worker and a breast cancer survivor. This comprehensive handbook provides jargon-free information on the wide range of practical issues women face as they navigate the journey back to health, including: •Managing physical...
	Breast cancer metastasis to the gasserian ganglion.(Letters to the Editor): An article from: Southern Medical Journal by Federico L. Ampil (Author), Gary V. Burton (Author), Mardjohan Hardjasudarma (Author), Travis Henley (Author) This digital document is an article from Southern Medical Journal, published by Thomson Gale on January 1, 2006. The length of the article is 762 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Breast cancer metastasis to the gasserian ganglion.(Letters to the Editor) Author: Federico L. Ampil Publication: Southern Medical Journal (Magazine/Journal) Date: January 1, 2006 Publisher: Thomson Gale Volume: 99 Issue: 1 Page: 93(2) Distributed by Thomson...
	NEW TEST MAY PREDICT BREAST CANCER METASTASIS.: An article from: Biotech Business by Gale Reference Team (Author) This digital document is an article from Biotech Business, published by Worldwide Videotex on May 1, 2009. The length of the article is 1086 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: NEW TEST MAY PREDICT BREAST CANCER METASTASIS. Author: Gale Reference Team Publication: Biotech Business (Newsletter) Date: May 1, 2009 Publisher: Worldwide Videotex Issue: 5 Page: NA Distributed by Gale, a part of Cengage Learning
	Holding Tight, Letting Go: Living with Metastatic Breast Cancer by Musa Mayer (Author) This is a book about life: the daily lives of ordinary people confronting a deadly disease.Holding Tight, Letting Go offers the stories of 40 women and men as they struggle to come to terms with metastatic breast cancer. All aspects of dealing with the disease are covered here: from coping with the shock of recurrence and seeking information, to making treatment decisions, investigating alternative and complementary methods, and communicating effectively with medical personnel. Finding sources of emotional support from other patients and friends and dealing with relationship and family issues are often as important as managing the side effects of treatment and the pain and symptoms of disease progression.Frank and moving descriptions from those who have been there make their stories...
	Handbook of Metastatic Breast Cancer by Stephen Johnston (Author), Charles Swanton (Author) There used to be limited therapeutic options for women who developed metastatic breast cancer. However, recent development with novel systemic drugs and palliative surgical techniques, together with advances in diagnostic imaging, have given new hope for these patients and made the treatment of these patients considerably more challenging. One convenient source bringing together the various relevant aspects is long overdue. This handbook covers treatment for both the cancer and the complications that can arise from treatment itself.
	Metastasis of Breast Cancer (Cancer Metastasis - Biology and Treatment): 11 by Springer Metastasis (spread of cancer in the body) is the main cause of death for patients with breast cancer, the leading female tumour in the industrialised countries and developing countries alike. The biology and treatment of breast cancer metastasis remains an active area of scientific and clinical investigation. Written by experts in the subject area, the book has covered a broad range of topics in the metastasis of breast cancer, from genetics, biology to clinical management. Main topics include genetic control, biology, growth factors, cell adhesion, cell motility and invasion, natures of bone metastasis, sentinel node therapies, hormonal links, new biomarkers and detection of micrometastasis, and diagnosis The book also covers the current treatment options including surgical...